Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder

NCT04044664 is registered in ClinicalTrials.gov with Aptinyx as lead sponsor.

NCT NCT04044664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04044664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder
Lead sponsor
Aptinyx
Phase
Phase 2
Overall status
Completed
Start date
January 25, 2019
Completion date
August 5, 2020
Enrollment
160 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder